Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hemoglobin is a **tetrameric metalloprotein** found predominantly in erythrocytes (red blood cells)[9]. It consists of four globin polypeptide chains, each with an iron-containing heme group, allowing one molecule of hemoglobin to bind up to four oxygen molecules cooperatively[1][4][7][8][9]. Hemoglobin binds oxygen in the lungs and releases it at tissues with lower oxygen tension, driven by allosteric changes influenced by pH, CO₂, temperature, and 2,3-bisphosphoglycerate levels[1][7][9]. This process is essential for aerobic metabolism in all tissues. Hemoglobin also plays a role in transporting carbon dioxide and regulating blood flow through interactions with nitric oxide[2][3]. Disorders of hemoglobin production, structure, or regulation lead to diseases such as anemia and hemoglobinopathies.
Increasing hemoglobin synthesis or stability (erythropoietin, iron) Enhancing oxygen binding/release dynamics (experimental) Reducing abnormal hemoglobin polymerization (hydroxyurea in sickle cell disease)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemoglobin (adult) (Hb or Hgb).